Tyra biosciences announces appointments of susan moran, m.d., m.s.c.e. and s.

Carlsbad, calif. , may 7, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced changes to its board of directors with the appointments of susan moran, m.d.
TYRA Ratings Summary
TYRA Quant Ranking